Here are five things to know:
1. The new product features a resorbable mesh made of demineralized bone matrix.
2. The OsteoBallast Demineralized Bone Matrix is intended to simplify graft placement as well as reduce graft movement.
3. SeaSpine designed the product to help with graft delivery during posterior spine surgery.
4. Surgeons will likely find the product especially useful for minimally invasive spine surgeries.
5. SeaSpine reported it will initiate a limited release of the new product in 2017 with a full launch by mid-2018.
More articles on biologics:
MD Stem Cells reports positive initial results for SCI study: 5 insights
FDA clarifies regenerative medicine policies with new framework — 5 things to know
Private clinics promoting unapproved stem cell treatments in Canada: 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
